Skip to main content

Table 3 The occurrence and improvement of renal damage in different groups

From: Efficacy and nephrotoxicity of polymyxin B in elderly patients with carbapenem resistant bacterial infection

Group

No-AKI incidence [n (%)]

AKI incidence [n (%)]

[n (%)]

Effective group

Ineffective group

[n (%)]

Effective group

Ineffective group

No renal injury group (n = 124)

96 (77.4%)a

62 (64.6%)

34 (35.4%)

28 (22.6%)

5 (17.9%)

23 (82.1%)

Chronic renal injury (n = 48)

13 (27.1%)

8 (61.5%)

5 (38.5%)

35 (72.9%)

12 (34.3%)

23 (65.7%)

Acute renal injury group (n = 43)

26 (60.5%)b

17 (65.4%)

9 (34.6%)

17 (39.5%)

5 (29.4%)

12 (70.6%)

Total (n = 215)

135 (62.8%)

87 (64.4%)

48 (35.6%)

80 (37.2%)

22 (27.5%)c

58 (72.5%)

  1. Comparison of no AKI incidence: compared with the chronic renal injury group before treatment, aP < 0.01; Acute renal injury group before treatment versus the chronic renal injury group before treatment, bP < 0.01
  2. Comparing AKI incidence, cP < 0.05 in the effective treatment group versus the ineffective treatment group
Back to article page

Annals of Clinical Microbiology and Antimicrobials

ISSN: 1476-0711

Contact us